Global /Denmark /Healthcare /Medical Devices /COLO-B
chevron_leftBack
Coloplast A/S logo

Coloplast A/S

COLO-B
CPH: COLO-B Delayed
398.10DKK -2.5%
61.40 USD
As of 9 June 2026, Coloplast A/S has a market cap of $14.18B USD, ranking #1645 globally and #10 in Denmark. It ranks #123 in the Healthcare sector, and #32 in the Medical Devices industry.
Global Rank
1645
Country Rank
10
Sector Rank
123
Industry Rank
32
Key Stats
Market Cap
$14.18BUSD
91.91B DKK
Enterprise Value
$17.87BUSD
115.88B DKK
Revenue (TTM)
$4.3BUSD
27.89B DKK
EBITDA (TTM)
$1.32BUSD
8.58B DKK
Net Income (TTM)
$615.27MUSD
3.99B DKK
EBITDA Margin
31%
Profit Margin
14%
PE Ratio
23.1
Forward PE
16.1
PS Ratio
3.3
PB Ratio
6.7
EV/EBITDA
13.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Lars Rasmussen open_in_new
Employees
16,983
Founded
1954
Website
coloplast.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.5% -6.8% -7.3% -25% -33% -45%

News

Loading...

Markets

Exchange Ticker Price
Nasdaq Copenhagen
MIC: XCSE
PRIMARY
COLO-B
Coloplast AS Class B
ISIN: DK0060448595
Shares Out.:
207.367M1 Shares Float: 142.815M2
TV:
SA:
YF:
GF:
BA:
MS:
398.10 DKK
London Stock Exchange
MIC: XLON
0QBO
Coloplast AS Class B
ISIN: DK0060448595
TV:
SA:
YF:
GF:
BA:
MS:
406.12 DKK
Mexican Bolsa
MIC: XMEX
0QBO (0QBO/N)
Coloplast AS Class B
ISIN: DK0060448595
TV:
SA:
YF:
GF:
BA:
MS:
1,875.47 MXN
Show all 9 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Similar Companies

Industry: Medical Devices (Denmark)
Name
Market Cap diff.
PE
DEMANT
$6.51B
42.18B DKK
-54%
17.9
AMBU-B
$2.65B
17.18B DKK
-81%
31.8
CHEMM
$855.72M
5.55B DKK
-94%
31.3
CURAS
$162.65M
1.05B DKK
-99%
-
BIOPOR
$75.91M
492.14M DKK
-99%
-
VIRO
$15.03M
97.46M DKK
-100%
-
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
1K%
25.8
$160.73B
1K%
56.7
$159.07B
1K%
25.6
DHR
$126.55B
793%
34.7
SYK
$120.69B
751%
38.3
MDT
$101.9B
619%
22.2
chevron_leftBack